Newsroom

Press Release

NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials

NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients